Economic Evaluations Conducted for Assessment of Genetic Testing Technologies: A Systematic Review

2012 ◽  
Vol 16 (11) ◽  
pp. 1322-1335 ◽  
Author(s):  
Nazila Assasi ◽  
Lisa Schwartz ◽  
Jean-Eric Tarride ◽  
Ron Goeree ◽  
Feng Xie
Keyword(s):  
Systematic Review ◽  
Genetic Testing ◽  
Economic Evaluations

scholarly journals Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations

2016 ◽  
Vol 18 (12) ◽  
pp. 1171-1180 ◽  
Author(s):  
Elvira D’Andrea ◽  
Carolina Marzuillo ◽  
Corrado De Vito ◽  
Marco Di Marco ◽  
Erica Pitini ◽  
...  
Keyword(s):  
Systematic Review ◽  
Health Care ◽  
Genetic Testing ◽  
Economic Evaluations ◽  
Brca Genetic Testing

scholarly journals PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies

2011 ◽  
Vol 14 (7) ◽  
pp. A260
Author(s):  
N. Assasi ◽  
L. Schwartz ◽  
J.E. Tarride ◽  
R. Goeree ◽  
F. Xie
Keyword(s):  
Systematic Review ◽  
Genetic Testing ◽  
Economic Evaluations

scholarly journals PMC2 A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF GENETIC TESTING TECHNOLOGIES

2005 ◽  
Vol 8 (3) ◽  
pp. 375
Author(s):  
S Ramsey ◽  
N Henrikson ◽  
J Carlson ◽  
DL Veenstra
Keyword(s):  
Systematic Review ◽  
Genetic Testing ◽  
Economic Evaluations

scholarly journals Correction to: Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique

2019 ◽  
Vol 17 (3) ◽  
pp. 419-419
Author(s):  
Rajan Sharma ◽  
Yuanyuan Gu ◽  
Teresa Y. C. Ching ◽  
Vivienne Marnane ◽  
Bonny Parkinson
Keyword(s):  
Systematic Review ◽  
Hearing Loss ◽  
Economic Evaluations ◽  
Childhood Hearing Loss

Telestroke for acute ischaemic stroke: A systematic review of economic evaluations and a de novo cost–utility analysis for a middle income country

2021 ◽  
pp. 1357633X2110324
Author(s):  
Elise Tan ◽  
Lan Gao ◽  
Huong NQ Tran ◽  
Dominique Cadilhac ◽  
Chris Bladin ◽  
...  
Keyword(s):  
Systematic Review ◽  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Rural China ◽  
Stroke Care ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Sensitivity Analyses ◽  
Economic Evaluations ◽  
Utility Analysis

Introduction Telemedicine can alleviate the problems faced in rural settings in providing access to specialist stroke care. The evidence of the cost-effectiveness of this model of care outside high-income countries is limited. This study aimed to conduct: (a) a systematic review of economic evaluations of telestroke and (b) a cost–utility analysis of telestroke, using China as a case study. Methods We systematically searched Embase, Medline Complete and Cochrane databases. Inclusion criteria: full economic evaluations of telemedicine/telestroke networks examining the use of thrombolysis in patients with acute ischaemic stroke, published in English. A cost–utility analysis was undertaken using a Markov model incorporating a decision tree to simulate the delivery of telestroke for acute ischaemic stroke in rural China, compared to no telestroke from a societal and healthcare perspective. One-way deterministic sensitivity analyses and probabilistic sensitivity analyses were performed to test the robustness of results. Results Of 559 publications found, eight met the eligibility criteria and were included in the systematic review (two cost-effectiveness analyses and six cost–utility analyses, all performed in high-income countries). Telestroke was a cost-saving/cost-effective intervention in five out of the eight studies. In our modelled analysis for rural China, telestroke was the dominant strategy, with estimated cost savings of Chinese yuan 4,328 (US$627) and additional 0.0925 quality-adjusted life years per patient. Sensitivity analyses confirmed the base case results. Discussion Consistent with published economic evaluations of telestroke in other jurisdictions, telestroke represents a cost-effective solution to enhance stroke care in rural China.

scholarly journals Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review

2019 ◽  
Vol 22 (2) ◽  
pp. 258-267 ◽  
Author(s):  
Sharon J. M. Kessels ◽  
Drew Carter ◽  
Benjamin Ellery ◽  
Skye Newton ◽  
Tracy L. Merlin
Keyword(s):  
Systematic Review ◽  
Cystic Fibrosis ◽  
Genetic Testing ◽  
Clinical Effectiveness ◽  
Prenatal Genetic Testing ◽  
Ethics Review
Sign in / Sign up

Export Citation Format

Share Document